NC-4016 DACH-Platin Micelle / Indication : Cancer

Phase I Clinical Trial

Oxaliplatin (generic name) is a platinum-based chemotherapy drug used in the treatment of bowel cancer (colorectal cancers). Side effects of oxaliplatin treatment can potentially include severe peripheral neuropathy such as numbness or tingling.

The basic technology of this formulation was invented by Professor Kataoka of the University of Tokyo. The technology was licensed in from TOUDAI TLO Ltd. The basic Japanese patent has been granted as Patent No. 39955992.
Estimation Structure of NC-4016